Metabolix (MBLX) Reports Q3 Loss of $0.05/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Metabolix Announces Third Quarter 2016 Financial Results
November 9, 2016 4:06 PM ESTCAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ: MBLX), today reported financial results for the three months ended September 30, 2016.
We are excited to be moving forward focusing exclusively on the Yield10 Bioscience mission to address the challenge of global food security, said Oliver Peoples, Ph.D., president and chief executive officer. We sold and transferred our legacy biopolymer assets to CJ CheilJedang. In addition, we completed winding down biopolymer related activities and substantially completed the restructuring of the business. We recently announced the Yield10 management team, and we are now directing our... More
